Sarepta Therapeutics, Inc.

SRPT

Sarepta Therapeutics, Inc.

SRPT

Insider Sentiment (TTM):

Last Purchase:2024-08-16Last Sale:2026-03-12Shares Purchased (TTM):0Shares Sold (TTM):20,426

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:99,306,705Shares Outstanding:104,988,000Institutional Ownership Pct.:94.59%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	571	464	801	613	511	241	1,103	198	384	427	428	542
Short Term Investments	217	189	138	238	290	282	252	1,001	1,077	963	1,248	1,192
Accounts Receivable Net Current	377	395	398	396	527	659	602	435	360	379	400	319
Inventory Net	904	1,001	915	1,077	994	941	750	566	486	374	323	244
Other Assets Current	106	188	172	192	128	105	90	165	75	83	78	154
Assets Current	2,224	2,310	2,538	2,722	2,657	2,433	3,073	2,685	2,684	2,465	2,579	2,451
Property Plant And Equipment Net	326	336	345	359	372	361	340	306	276	249	227	212
Operating Lease Right Of Use Asset	121	124	125	139	143	147	148	141	124	126	130	133
Inventory Noncurrent	226	175	185	199	195	181	188	203	205	208	191	176
Long Term Investments	145	82	1	1	35	109	133	182	-	-	0	-
Other Assets Noncurrent	146	152	156	73	83	81	80	84	136	176	137	137
Assets	3,189	3,179	3,350	3,493	3,680	3,465	3,963	3,600	3,424	3,224	3,265	3,110
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	51	70	281	94	137	156	214	119	107	92	165	88
Accrued Liabilities Current	325	302	360	296	377	392	374	345	350	283	315	322
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	-	18	-
Business Combination Contingent Consideration Liab…	-	-	-	36	-	-	-	-	-	-	-	-
Contract With Customer Liability Current	110	116	443	485	395	45	130	127	122	112	50	22
Long Term Debt Current	-	-	-	-	-	-	0	92	92	106	105	-
Other Liabilities Current	17	10	11	10	10	13	13	17	17	16	18	18
Liabilities Current	503	499	1,095	921	920	606	732	699	688	609	654	451
Long Term Loans Payable	848	838	829	1,035	1,139	1,138	1,137	1,136	1,135	1,134	1,133	1,237
Operating Lease Liability Noncurrent	198	199	199	215	214	205	192	170	144	140	141	135
Contract With Customer Liability Noncurrent	110	136	84	0	0	325	325	325	325	325	437	485
Business Combination Contingent Consideration Liab…	-	-	0	0	-	-	47	-	-	-	-	-
Other Liabilities Noncurrent	2	2	2	1	1	1	2	1	7	8	3	0
Business Combination Contingent Consideration Liab…	-	-	47	-	47	47	47	47	48	48	38	38
Liabilities	1,661	1,674	2,209	2,173	2,322	2,323	2,435	2,379	2,347	2,263	2,405	2,345
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Value	-25	-25	-25	-25	-25	-	0	-	-	-	-	-
Additional Paid In Capital Common Stock	6,105	6,077	6,043	5,987	5,844	5,801	5,739	5,589	5,482	5,372	5,305	5,257
Accumulated Other Comprehensive Income Loss Net Of…	-1	-0	0	0	-0	0	-0	2	-1	-1	1	-1
Retained Earnings Accumulated Deficit	-4,551	-4,546	-4,877	-4,642	-4,462	-4,658	-4,211	-4,370	-4,404	-4,410	-4,446	-4,492
Stockholders Equity	1,528	1,505	1,141	1,320	1,405	1,143	1,528	1,221	1,077	961	859	764
Liabilities And Stockholders Equity	3,189	3,179	3,350	3,493	3,680	3,465	3,963	3,600	3,424	3,224	3,265	3,110
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	3	3	3	3	3	3	3	3	3	3	3	3
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	198	198	198	198	198	198	198	198	198	198	198	198
Common Stock Shares Issued	106	106	106	105	98	98	97	95	95	94	94	94
Shares Outstanding	106	106	105	105	98	98	97	95	95	94	94	94
Treasury Stock Common Shares	1	1	1	1	1	-	0	-	-	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-22.41%	-26.83%	-31.91%	-	-	-	-	-	-	-	-	-
2025	-19.57%	-63.40%	-74.48%	11.93%	12.92%	40.28%	20.98%	25.40%	19.78%	22.37%	24.39%	2.94%
2024	-5.68%	22.78%	11.24%	-3.06%	-11.09%	-6.37%	4.20%	-5.06%	-8.99%	-30.59%	-49.61%	-65.87%
2023	-	-	-	-	-	-	8.30%	23.55%	51.12%	-7.24%	-15.91%	-4.45%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.42	4.63	2.32	2.95	2.89	4.02	4.20	3.84	3.90	4.05	3.95	5.44
Quick Ratio	2.62	2.62	1.48	1.79	1.81	2.46	3.18	3.03	3.19	3.44	3.45	4.90
Working Capital	1.72B	1.81B	1.44B	1.80B	1.74B	1.83B	2.34B	1.99B	2.00B	1.86B	1.93B	2.00B
Leverage & Debt
Debt to Equity	1.09	1.11	1.94	1.65	1.65	2.03	1.59	1.95	2.18	2.35	2.80	3.07
Debt Ratio	0.52	0.53	0.66	0.62	0.63	0.67	0.61	0.66	0.69	0.70	0.74	0.75
Efficiency & Turnover
Asset Turnover TTM	0.50	0.58	0.60	0.62	0.63	0.63	0.53	0.49	0.47	0.45	0.39	0.35
Days Sales Outstanding TTM	95.22	100.35	83.04	69.17	71.96	90.22	96.17	83.45	71.32	78.37	90.26	87.73
Receivables Turnover TTM	3.83	3.64	4.40	5.28	5.07	4.05	3.80	4.37	5.12	4.66	4.04	4.16
Per Share Metrics
Diluted EPS TTM	-1.30	0.53	-7.13	-2.71	-0.54	-2.55	2.18	1.21	0.48	0.17	-5.80	-7.77
Free Cash Flow Per Share TTM	0.78	1.09	-3.07	-3.80	-4.61	-7.14	-3.60	-4.93	-5.36	-6.73	-6.25	-6.79
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-8.27%	-2.14%	-31.83%	-5.78%	-0.04%	-5.58%	11.47%	4.92%	2.49%	-6.76%	-21.54%	-36.89%
Net Profit Margin TTM	-7.89%	3.39%	-32.45%	-12.40%	-2.58%	-11.83%	12.37%	7.39%	3.10%	1.20%	-43.11%	-63.82%
Growth Metrics
Net Revenue Growth (1Y)	-22.99%	-8.71%	15.58%	32.94%	47.34%	49.65%	52.97%	52.21%	52.20%	43.83%	33.26%	37.67%
Net Income Growth (1Y)	135.91%	-126.19%	-403.27%	-322.84%	-222.54%	-1,570.01%	-143.89%	-117.64%	-105.21%	-101.52%	-23.81%	-3.54%
EPS Growth (1Y)	119.30%	-124.29%	-387.99%	-312.06%	-218.30%	-1,519.12%	-142.65%	-116.43%	-104.89%	-101.42%	-27.80%	-4.91%
Valuation Metrics
P/E TTM	-13.86	35.12	-3.02	-7.11	-28.92	-25.02	49.14	97.77	316.08	720.13	-16.62	-15.60
P/B TTM	1.24	1.52	1.89	1.46	1.19	5.44	7.57	9.76	13.88	12.66	10.37	14.10
P/S TTM	1.09	1.19	0.98	0.88	0.74	2.96	6.08	7.23	9.79	8.67	7.17	9.95
Market Cap	1.89B	2.28B	2.15B	1.93B	1.68B	6.21B	11.56B	11.91B	14.95B	12.17B	8.91B	10.78B
Enterprise Value	1.31B	1.81B	1.34B	1.31B	1.15B	5.96B	11.51B	11.79B	14.64B	11.83B	8.59B	10.23B
Calculated Values
Free Cash Flow TTM	81.85M	114.87M	-307.45M	-381.10M	-451.55M	-695.31M	-342.74M	-470.40M	-506.82M	-632.74M	-577.10M	-603.76M
Net Debt	-581.27M	-477.58M	-814.41M	-626.20M	-526.18M	-256.45M	-47.51M	-121.84M	-307.70M	-337.28M	-322.95M	-541.93M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-12Sale

Owner: Mayo, Stephen

Title: -

Shares: 7,239

Price/Share: $17.02

Value: $123,207.78

Shares Owned: 1,765

Relationship: Director

Ownership: Direct

2025-12-16Sale

Owner: Estepan, Ian Michael

Title: Chief Operating Officer

Shares: 13,187

Price/Share: $22.31

Value: $294,201.97

Shares Owned: 193,300

Relationship: Officer

Ownership: Direct

2025-03-12Sale

Owner: Nicaise, Claude

Title: -

Shares: 2,491

Price/Share: $99.64

Value: $248,203.24

Shares Owned: 27,812

Relationship: Director

Ownership: Direct

2024-12-12Sale

Owner: Wigzell, Hans Lennart Rud…

Title: -

Shares: 10,500

Price/Share: $124.84

Value: $1,310,820.00

Shares Owned: 22,840

Relationship: Director

Ownership: Direct

2024-12-05Sale

Owner: Boor, Kathryn Jean

Title: -

Shares: 1,636

Price/Share: $125.55

Value: $205,399.80

Shares Owned: 5,880

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-12	Mayo, Stephen	Director	-	Direct	Sale	7,239	17.02	$123,207.78	1,765	4
2025-12-16	Estepan, Ian Michael	Officer	Chief Operating Officer	Direct	Sale	13,187	22.31	$294,201.97	193,300	4
2025-03-12	Nicaise, Claude	Director	-	Direct	Sale	2,491	99.64	$248,203.24	27,812	4
2024-12-12	Wigzell, Hans Lennart Rud…	Director	-	Direct	Sale	10,500	124.84	$1,310,820.00	22,840	4
2024-12-05	Boor, Kathryn Jean	Director	-	Direct	Sale	1,636	125.55	$205,399.80	5,880	4
2024-08-30	Estepan, Ian Michael	Officer	Chief Financial Officer	Direct	Sale	5,985	137.36	$822,099.60	33,946	4
2024-08-16	Chambers, Michael Andrew	Director	-	Indirect	Purchase	37,038	133.93	$4,960,499.34	284,034	4
2024-06-25	Brown, Ryan Edward	Officer	EVP, General Counsel	Direct	Sale	38,957	161.43	$6,288,828.51	17,129	4
2024-06-25	Arif, Bilal	Officer	Chief Tech Ops Officer	Direct	Sale	3,898	163.23	$636,270.54	17,363	4
2024-05-02	Murray, Dallan	Officer	Chief Customer Officer	Direct	Sale	3,635	140.00	$508,900.00	18,125	4
2024-03-11	Boor, Kathryn Jean	Director	-	Direct	Sale	761	122.93	$93,549.73	7,516	4
2024-03-08	Wigzell, Hans Lennart Rud…	Director	-	Direct	Sale	15,000	123.11	$1,846,650.00	22,840	4
2024-03-05	Mayo, Stephen	Director	-	Direct	Sale	3,135	122.96	$385,479.60	6,621	4
2024-03-01	Arif, Bilal	Officer	Chief Tech Ops Officer	Direct	Sale	2,000	129.15	$258,300.00	26,836	4
2024-03-01	Estepan, Ian Michael	Officer	Chief Financial Officer	Direct	Sale	1,200	128.30	$153,960.00	39,114	4
2024-03-01	Brown, Ryan Edward	Officer	EVP, General Counsel	Direct	Sale	2,000	125.34	$250,680.00	31,827	4
2023-11-03	Ingram, Douglas S	Director,Officer	President & CEO	Direct	Purchase	25,225	79.96	$2,016,991.00	390,307	4
2023-11-03	Barry, Richard	Director	-	Indirect	Purchase	50,000	78.81	$3,940,500.00	140,000	4
2023-08-14	Chambers, Michael Andrew	Director	-	Indirect	Purchase	9,979	109.54	$1,093,099.66	246,996	4
2023-08-11	Chambers, Michael Andrew	Director	-	Indirect	Purchase	23,686	108.05	$2,559,272.30	237,017	4
2023-08-10	Chambers, Michael Andrew	Director	-	Indirect	Purchase	34,867	105.61	$3,682,303.87	213,331	4
2023-08-04	Wigzell, Hans Lennart Rud…	Director	-	Direct	Sale	15,000	106.72	$1,600,800.00	20,994	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

94.59%

Inst. Shares: 99,306,705

Shares Outstanding: 104,988,000

2025-12-31

90.24%

Inst. Shares: 90,345,619

Shares Outstanding: 100,120,000

2025-09-30

82.96%

Inst. Shares: 83,159,374

Shares Outstanding: 100,237,000

2025-06-30

81.82%

Inst. Shares: 80,185,071

Shares Outstanding: 98,005,000

2025-03-31

83.83%

Inst. Shares: 81,621,358

Shares Outstanding: 97,362,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	99,306,705	104,988,000	94.59%
2025-12-31	90,345,619	100,120,000	90.24%
2025-09-30	83,159,374	100,237,000	82.96%
2025-06-30	80,185,071	98,005,000	81.82%
2025-03-31	81,621,358	97,362,000	83.83%
2024-12-31	82,466,457	95,075,000	86.74%
2024-09-30	80,633,468	95,390,000	84.53%
2024-06-30	83,382,222	94,618,000	88.13%
2024-03-31	76,179,640	93,991,000	81.05%
2023-12-31	74,865,113	92,398,000	81.02%
2023-09-30	74,925,902	88,889,000	84.29%
2023-06-30	76,426,186	88,743,000	86.12%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Sarepta Therapeutics, Inc. (SRPT) — SEC Financial Statements & Analysis

Sarepta Therapeutics, Inc. (SRPT) is a pharmaceutical preparations company, incorporated in DE. Sarepta Therapeutics, Inc. trades on Nasdaq as: SRPT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Sarepta Therapeutics, Inc. reported a -22.99% year-over-year revenue growth, a Debt-to-Equity ratio of 1.09x, a Price-to-Sales (P/S) ratio of 1.09x (TTM), a Price-to-Book (P/B) ratio of 1.24x (TTM), at a market cap of $1.89B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -22.99%
Debt To Equity: 1.09x
P/S TTM: 1.09x
P/B TTM: 1.24x
Market Cap: $1.89B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Sarepta Therapeutics, Inc. in?

Sarepta Therapeutics, Inc. (SRPT) operates in the Pharmaceutical Preparations industry.

What is SRPT's market cap?

Sarepta Therapeutics, Inc. (SRPT) has a market capitalization of $1.89B as of 2026-06-30.

What exchange does SRPT trade on?

Sarepta Therapeutics, Inc. (SRPT) trades on the Nasdaq.

Where is Sarepta Therapeutics, Inc. incorporated?

Sarepta Therapeutics, Inc. is incorporated in DE.